TY  - JOUR
TI  - Evaluation of the Efficacy and Safety of D-Colefor (25-OH Vitamin D) Patients
AB  - Objective: This study evaluates the vitamin D results inpatients diagnosed with vitamin D deficiency and used the oral vitamin D in capsule form twice a week for 2x20000UI during eight weeks (D-Colefor 14 capsules). Material and Methods: Patients who were found to have vitamin D deficiency and whose vitamin D level was 20 ng/dl and below, who used oral vitamin D (D-Colefor capsule) 40000 IU per week (2X20000 IU for two days) for eight weeks and whose vitamin D measurement was made at the end of eight weeks were included in the study. Our study was conducted retrospectively bys scanning patient files. We planned to investigate the treatment results by determining the percentage of patients whose vitamin D level exceeded 30 ng/dl, which was considered sufficient, after eight weeks. Results: It was determined that the use of the capsule form of oral vitamin D twice a week for eight weeks for 2x20000 IU increased serum vitamin D levels of 58.8% of the patients to the adequate dose of 30 ng/dl and above.
AU  - Duman, Gülhan
AU  - SARIAKÇALI, BARIS
AU  - TUNAHAN, HASAN
PY  - 2021
JO  - Ege Klinikleri Tıp Dergisi
VL  - 59
IS  - 3
SN  - 2148-0990
SP  - 300
EP  - 303
DB  - TRDizin
UR  - http://search/yayin/detay/486842
ER  -